
COVIDã¯ã¯ãã³ã¯ã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ãããè³è¡æ ãè³åäžã®ãªã¹ã¯ã112,000ïŒ é«ã
å èšäºã¯ãã¡ããã/Click here to read the original article.
å é±ãInternational Journal of Innovative Research in Medical Scienceã«æ²èŒãããæ»èªä»ãç ç©¶ã§ã¯ãCOVID-19æ¥çš®åŸã«è³è¡æ 塿 çãçºçããçäŸã36ã¶æéã§5,137äŸå ±åãããã®ã«å¯Ÿããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®åŸã«çºçããçäŸã¯52äŸãéå»34幎éã®å šã¯ã¯ãã³æ¥çš®åŸã®çäŸã¯282äŸã§ãã£ãã
COVID-19ã¯ã¯ãã³ã¯ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãããè³è¡æ ãè³åäžã®ãªã¹ã¯ã112,000ïŒ é«ããä»ã®ãã¹ãŠã®ã¯ã¯ãã³ãåãããããã20,700ïŒ é«ããšããæ»èªä»ãç ç©¶ãçºè¡šãããã
ã€ã³ã¿ãŒãã·ã§ãã«ã»ãžã£ãŒãã«ã»ãªãã»ã€ãããŒãã£ãã»ãªãµãŒãã»ã€ã³ã»ã¡ãã£ã«ã«ã»ãµã€ãšã³ã¹èªã«å é±çºè¡šããããã®ç ç©¶ã§ã¯ãCOVID-19ã®æ¥çš®åŸã«è³è¡æ 塿 çãçºçããçäŸã36ã¶æéã§5,137ä»¶å ±åãããŠãããããã¯ãéå»34幎éã«ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®åŸã«å ±åããã52çäŸããã¹ãŠã®ã¯ã¯ãã³æ¥çš®åŸã«å ±åããã282çäŸãšæ¯èŒãããã®ã§ããã
ç ç©¶ã«ããã°ãããã¯COVID-19ã¯ã¯ãã³æ¥çš®åŸã®ãè³è¡æ çã®æå®³äºè±¡ã«é¢ããå®å šæ§ã·ã°ãã«ã®éŸå€ã®ææ ®ãã¹ãéåããæå³ããã
æ¬ç ç©¶ã®èè ã§ããç¬ç«ç ç©¶è ã¯ã¬ã¢ã»ããžã£ãŒã¹ãç£å©Šäººç§å»ãžã§ãŒã ã¹ã»Aã»ãœãŒãå士ãç¬ç«ç ç©¶è ã«ãŒã¹ãã£ã³ã»ã³ã¹ã°ããŒããå¿èå°éå»ããŒã¿ãŒã»ããã«ããŒå士ã¯ãç±³åœæ¿åºã®ã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ïŒVAERS ïŒã®ããŒã¿ãåæã«äœ¿çšããã
ãã®ããŒã¿ã«ã¯ãCOVID-19ã¯ã¯ãã³æ¥çš®åŸã«å¿æ¿çްåïŒãè³åèè¡æ 塿 çã®æãäžè¬çãªç¹å®å¯èœãªåå ãã§ããäžæŽèïŒã41ã¶æéã§9,821ä»¶å ±åãããããšã瀺ãããŠãããä»ã®ãã¹ãŠã®ã¯ã¯ãã³ãåããã34幎éã§å ±åããã797ä»¶ãšæ¯èŒããŠããã
ããžã£ãŒãºæ°ã¯ããã®èª¿æ»çµæã¯ãCOVID-19ãã³ãããã¯äžãšãã®åŸã«è³åäžã®çºççãå¢å ãããšããéžè©±ç蚌æ ãè£ä»ãããã®ã§ãããšDefenderçŽã«èªã£ãã
ããžã£ãŒãºæ°ã¯èšãïŒ
ãVAERSã«ãããè³è¡æ ççäŸå ±åã¯ãCOVIDã¯ã¯ãã³æ¥çš®åŸã«å€§å¹
ã«å¢å ããŸãããèšåºå»ãç
é¢å
ã§ç®æããã ãã§ãªããäžè¬åžæ°ãæå人ãã¹ããŒãéžæãè¥ã人ãã¡ã®è³åäžã®å ±åãå¢ããŠããã®ãç®ã«ããŠããŸããã
McCulloughæ°ã¯ããã®ç 究㯠ãåççãªã¯ã¯ãã³å®å
šæ§ç ç©¶æŠç¥ ããæ¡çšãããæ°ããã¯ã¯ãã³ãš ãå®å
š ãåºæºãšããŠã®å®æçãªã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®ãæ¯èŒãã ããšDefenderçŽã«èªã£ãããã®çµæãCOVID-19ã¯ã¯ãã³æ¥çš®åŸã®ãæãããçµæãã瀺ããããšããã
ãããã®çµæããããã®ç ç©¶ã®èè
ãã¡ã¯ãCOVID-19ã¯ã¯ãã³ã®äœ¿çšãçŽã¡ã«äžççã«äžæåæ¢ããããšãæ±ããã
ãæã
ã®ç ç©¶ã¯ããã¹ãŠã®COVID-19ã¯ã¯ãã³ãåžå Žããæ€å»ããããšãæ±ããåæçµæã®å€§åå±ã«å ãã "ãšããã«ããŒã¯è¿°ã¹ããæ€éã¯æ¬¡ææ¿æš©ã«ãšã£ãŠ ãæåªå
äºé
ãã§ããã
ã¹ãã€ã¯ã¿ã³ãã¯è³ªãè³åäžãªã¹ã¯äžæã«é¢äž
ãã®ç ç©¶ã«ããã°ãSARS-CoV-2ãŠã€ã«ã¹ãšCOVID-19ã¯ã¯ãã³ã«å«ãŸããã¹ãã€ã¯èçœè³ªãè³è¡æ ãšè³åäžã®é倧ãªåå ã§ããå¯èœæ§ãé«ãã
ãCOVIDãã³ãããã¯ã®åæã«ãSARS-CoV-2ãŠã€ã«ã¹ã«è¡æ 圢æäœçšãããããšãæããã«ãªããçŸåšã§ã¯ã¹ãã€ã¯èçœè³ªããã®è¡æ 圢æäœçšã®äž»èŠãªèŠå ã®äžã€ã§ãããšèããããŠããã
ãã®ç ç©¶ã«ãããšããã®ãŠã€ã«ã¹ã®ãªãªãžãã«æ ªã¯ ãæ§ã ãªé節ãªè¡æ 塿 ç ããåŒãèµ·ããããããããæéã®çµéãšãšãã«ããèªç¶é²åã®çµæãç åæ§ã®äœãæ ªãçãŸããå¯èœæ§ããããã
ãã®åœåã®ãªã¹ã¯ã¯ã埮å°è¡æ ã®çºççã®å¢å ã«åã£ãŠä»£ããããã埪ç°ç³»ã®çްãè¡ç®¡ã«åœ±é¿ãåãŒã ãããã«ãªã£ãããã®ç ç©¶ã§ã¯ããã¹ãã€ã¯èçœè³ªãžã®çޝç©çãªæŽé²ã ãæ£è ã«ããããã®ãããªè¡æ ã®ãªã¹ã¯äžæã«ã€ãªããããšãåºãçè§£ãããŠãããšææããŠããã
ããžã£ãŒãºæ°ã«ããã°ããã¹ãã€ã¯èçœããã®ç æ ã«é¢äžãããšèããããäžã€ã®ã¡ã«ããºã ã¯ãå ç®æ©èœé害ãåŒãèµ·ããããšã§ããã
ãã®ç ç©¶ã§ã¯ãCOVID-19ã¯ã¯ãã³ã®çš®é¡-ãã¡ã€ã¶ãŒãšã¢ããã®mRNAã¯ã¯ãã³ããžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ïŒã€ã³ã»ã³ïŒãšã¢ã¹ãã©ãŒãã«ã®ã¢ãããŠã€ã«ã¹ããŒã¹ã®ã¯ã¯ãã³-ã¯æ¯èŒãããŠããªããããžã£ãŒãºæ°ã¯ãã¢ãããŠã€ã«ã¹ã¯ã¯ãã³ã¯ è¡æ ã®å ±åãåããŠç±³åœãšãšãŒãããã§äžæ¢ãããããšãææããŠããã
VAERSã¯çŸç 察çäºé²ã»ã³ã¿ãŒïŒCDCïŒãšç±³åœé£åå»è¬åå±ïŒFDAïŒã«ãã£ãŠ ãèŠå¶ãããææãããç¶æãããŠãã ãããšã«æ³šç®ãããã®ãããªåæã«ãã®ããŒã¿ããŒã¹ã䜿çšããããšã®çžå¯Ÿçãªå©ç¹ã𿬠ç¹ã«èšåããã
CDC/FDAã®åèŠãšãCOVID-19ã¯ã¯ãã³ã«ããæ»äº¡ãå·å®³ãé èœãé èœããã¹ãããã« ãããããšãã詊ã¿ã«ããããããã圌ãç¬èªã®åºæºãçšããåäŸã®ãªãå®å šã·ã°ãã«éåãæ®ã£ãŠããã
ãã®å®å šã·ã°ãã«ã¯ããVAERSã«ãããçžå¯Ÿçãªéå°å ±åçã¯......30ïœ100ã®ç¯å²ãšèããããŠãã ãã«ãããããããæçœã§ããã
2011幎ã®ããŒããŒã倧åŠã®ç ç©¶ã«ããã°ãVAERSã«å ±åãããæå®³äºè±¡ã¯å šäœã®1ïŒ æªæºã§ããã
COVID泚å°ã®ã¢ã©ããªã¢ã ãæ±ãã声ã匷ãŸã
Children's Health Defenseã®ã·ãã¢ã»ãªãµãŒãã»ãµã€ãšã³ãã£ã¹ãã§ããã«ãŒã«ã»ãžã£ããããŠã¹ããŒå士ã¯ããVAERSã®ããŒã¿ãããªã¹ã¯ãæšæž¬ããããšã«ã¯éçããããã«ããããããããã®ç ç©¶çµæã«ã¯ãé©ããããããšDefenderçŽã«èªã£ãã圌ã¯ãCOVID-19ã¯ã¯ãã³ã®æ¥çš®ãäžæåæ¢ããããæ±ãã声ãé«ãŸã£ãŠããããšã«ããã®ç ç©¶ãå ãã£ããšè¿°ã¹ãã
ãäžã€ã®ç ç©¶ãã¢ã©ããªã¢ã ãæ£åœåããããã§ã¯ãããŸããããäžååé³ã®ãããªç ç©¶ãã¢ã©ããªã¢ã ãæ£åœåããã®ã§ãã
ç ç©¶ã«ããã°ããçŸåšãæ»èªã®ããå»åŠéèªã«çºè¡šãããCOVID-19ã¯ã¯ãã³æ¥çš®åŸã®å·å®³ãéå®³ãæ»äº¡ãèšé²ããç ç©¶ã¯3,580ä»¶ã«ã®ãŒãããšããã
å æãã¢ã€ããå·å西éšä¿å¥å±ã¯ãå°å äœæ°ãããã«ããŒãã¹ã³ãŒããå«ãå°éå®¶ã®èšŒèšãåããCOVID-19ã¯ã¯ãã³ã®æäŸãäžæ¢ãããšçºè¡šããã
ããã«ç¶ããŠå æãã¹ãããã¢æ¿åºãmRNA泚å°ããå±éºããšãããã®çŠæ¢ãæ±ããå ±åæžãçºè¡šããããŸãå æã«ã¯ã西ãªãŒã¹ãã©ãªã¢å·ã®çºè°äŒãmRNA補å€ã®çŠæ¢ãæ±ããã
1æããããªãå·ã®ãžã§ã»ãã»ã©ããå€ç§éšé·ã¯ãå®å šæ§ã®æžå¿µãããCOVID-19 mRNAã¯ã¯ãã³ã®äœ¿çšåæ¢ããæ±ããã
ãããªãå·ã®10ã®é¡ã§æ¡æããã ãBan the Jabãæ±ºè°ã®èè ã§ããå¿ççæ³å®¶ã®ãžã§ã»ãã»ãµã³ãœã³å士ã¯ãCOVID-19ã¯ã¯ãã³ã®äžæåæ¢ãæ±ãããã®ç ç©¶ãæ¯æããã
圌ã¯èšãïŒ
ãCOVID-19ãšmRNAããç²å泚å°ã¯ãçç©åŠçã»æè¡ç倧éç Žå£å µåšã§ãããå»ççãçå®ãèªããä»ã®äººãã¡ãšåãããã«éšãããŠããããšãèªããæã§ãããããã®æ³šå°ã¯ããã®æè¡ã®æµå€±ã«ãã£ãŠã泚å°ãããè ãšæ³šå°ãããªãã£ãè ã«å®³ãåãŒãã
ããã¹ãŠã®mRNAããç²å泚å°ãçŽã¡ã«çŠæ¢ãããã®äººé¡ãžã®æ»æã®èåŸã«ããç¯çœªè ã培åºçã«èª¿æ»ããå¿ èŠãããã
äžçä¿å¥åè°äŒãCOVIDå«çãæ±ããå»åž«å£ãã¢ã¡ãªã«å»åž«å€ç§å»åäŒãªã©ã®å£äœãCOVID-19ã¯ã¯ãã³ã®ã¢ã©ããªã¢ã ãæ±ããŠããã
ãCOVIDã¯ã¯ãã³ã®äžè¬ãžã®æ®åç㯠é廿äœã§ããããã®ãããªè£œåã補é ããå¿ èŠæ§ã¯ãã¯ããªãã®ã§ããã
ã€ããããã¹ãã¯èšã£ãïŒ
ãCOVID-19ã¯ã¯ãã³ã®äžççãªã¢ã©ããªã¢ã ã¯ã人é¡ã®å¥åº·ã ãã§ãªããç§ãã¡ã®è¬èãã«ãšã£ãŠã倧ããªåé²ãšãªãã§ãããã
ãç§ãã¡ã¯å±éºãªè£œåã«éšãããæ¿åºãç§åŠè ã補è¬äŒç€ŸãããŸãã«ãåãã§ç§ãã¡ãéšããŠããããšãèªããªããã°ãªããªããç§ãã¡ã®æããæªæ¥ã¯ãç§ãã¡ããã®æ¡ä»¶ãåãå ¥ããããšããå§ãŸãã®ã§ããã